Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

• Role for immunology & nutrition in pancreatic canc

  A comparitive study of immunology and nutrition among patients with pancreatic cancer.

  View Trial

• NGM217

  A Phase 1 Randomized Double-Blind Placebo Controlled Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of NGM217 in Adults with Autoimmune Diabetes

  View Trial

• OuTSMART

  A randomized controlled clinical trial to determine if a combined screening /treatment programme can prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies.

  View Trial

• A Phase 2 Open-Label Single-Agent Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

  View Trial

• Evaluation of ultrasound probe for use in adaptive bladder radiotherapy

  View Trial

• OPTIMAS Trial

  OPtimal TIMing of Anticoagulation after acute ischaemic Stroke: a randomised controlled trial (OPTIMAS Trial)

  View Trial

• CORE

  A randomised trial of COnventional care versus Radioablation (stereotactic body radiotherapy) for Extracranial oligometastases

  View Trial

• PrePOINT (Primary Oral Insulin Trial)

  A dose-finding safety and immune efficacy study for primary mucosal insulin therapy in islet autoantibody negative children at high genetic risk for type 1 diabetes

  View Trial

• POUT

  A phase III randomised trial of Peri-Operative chemotherapy versus sUrveillance in upper Tract urothelial cancer

  View Trial

• ADDRESS-2

  An incident and high risk type 1 diabetes research cohort – After Diagnosis Diabetes REsearch Support System-2

  View Trial